Case ReportSofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C†
Under a Creative Commons license
open archive
Key words:
Calcineurin inhibitors
direct-acting antiviral agents
hepatitis C
polymerase inhibitors
Abbreviations
AST
aspartate aminotransferase
ALT
alanine aminotransferase
DCV
daclatasvir
HCV
hepatitis C virus
LT
liver transplantation
WBC
white blood count.
Cited by (0)
- †
Author contributions: Concept and design of the study (R.J.F., E.A.H., M.B., R.H.), generation, collection and analysis of data (R.J.F., E.A.H., M.B., H.A., D.D., R.H., W.T.S.), drafting of the manuscript (R.J.F., E.A.H., M.B., R.H., W.T.S.), finalization of manuscript (R.J.F., E.A.H., M.B., H.A., D.D., R.H., W.T.S.).
Copyright © 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.